Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

A prediction for this year from Jason Spangler, M.D., M.P.H., CEO, Center for Innovation & Value Research.

A new, first-of-its-kind study found that these symptoms occur particularly during the late menopause transition and ...

A Guideline Development Group (GDG) meeting at the end of the month aims to establish new guidelines for lenacapavir, a twice ...

Independence Blue Cross has begun excluding coverage for 18 months for therapies — but not cancer drugs — that have an ...

Gastric cancer, commonly known as stomach cancer, is the fifth most common cancer globally and the fifth leading cause of ...

Kamilia Smith, MD, FACOG, NCMP, discusses how shared decision-making approaches combined with emerging neurokinin-targeted therapies offer promising solutions to improve treatment adherence and ...

On January 5, Ashley began a demanding 14-day, 106-mile trek called “The Keys for a Cure” to raise funds and awareness for PF. Starting from mile marker 106 in Key Largo, he plans to walk an average ...

The updated guidelines from the American Diabetes Association emphasize the use of antibody-based screening for type 1 ...

Modern research shows women’s health issues go beyond reproductive health and highlight women’s elevated risk for autoimmune and cardiovascular disease – among other conditions.

Few studies in this analysis assessed the accuracy of AI in detecting melanoma in diverse skin tones. AI can detect skin cancer with 95% accuracy, but the technology won’t replace dermatologists until ...

Conventional drug development typically zeroes in on individual proteins or signaling pathways. By focusing on the ...